An Analyst Upgraded TherapeuticsMD Stock from “Perform” to “Outperform” Today
On Tuesday, after Jay Olson, an analyst at Oppenheimer, upgraded TherapeuticsMD (NYSEMKT:$TXMD) stock from “Perform” to “Outperform”, shares of TXMD increased 18%. Additionally, the analyst gave TherapeuticsMD shares a $10 price target, which means that ... [Read]
Lupin Limited Gets Final Go Ahead for its Oxycodone Hydrochloride Tablets
Lupin Limited (NSE: LUPIN), a major pharmaceutical company, has acquired the final approval from the United States FDA for its Oxycodone Hydrochloride tablets. These tablets will be used to treat patients suffering from severe pain. ... [Read]
Dr Reddy’s Calls for a Recall of $5,030 USD of Zenatane Tablets from US market
Are you thinking about investing in pharmaceutical companies? If so, let’s take a look at what’s been happening in this sector of the market as of late. Dr Reddy’s Laboratories (NYSE:$RDY), an Indian multinational pharmaceutical ... [Read]